Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,994,828
  • Shares Outstanding, K 126,041
  • Annual Sales, $ 739,020 K
  • Annual Income, $ -436,370 K
  • EBIT $ -442 M
  • EBITDA $ -404 M
  • 60-Month Beta 1.63
  • Price/Sales 13.65
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 55.66% (-15.90%)
  • Historical Volatility 44.18%
  • IV Percentile 15%
  • IV Rank 14.59%
  • IV High 103.43% on 04/04/25
  • IV Low 47.50% on 08/13/25
  • Expected Move (DTE 27) 9.98 (9.68%)
  • Put/Call Vol Ratio 0.70
  • Today's Volume 2,603
  • Volume Avg (30-Day) 1,054
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 23,099
  • Open Int (30-Day) 20,378
  • Expected Range 93.12 to 113.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.78
  • Number of Estimates 3
  • High Estimate -0.72
  • Low Estimate -0.82
  • Prior Year -0.77
  • Growth Rate Est. (year over year) -1.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
97.52 +5.72%
on 02/06/26
120.74 -14.61%
on 01/22/26
-11.77 (-10.25%)
since 01/20/26
3-Month
96.28 +7.08%
on 12/18/25
120.74 -14.61%
on 01/22/26
+2.80 (+2.79%)
since 11/20/25
52-Week
34.88 +195.58%
on 03/10/25
120.74 -14.61%
on 01/22/26
+55.70 (+117.51%)
since 02/20/25

Most Recent Stories

More News
Stocks Rally After Supreme Court Rejects President Trumps Tariffs

The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. U.S. equities climbed on Friday...

APO : 119.72 (+1.17%)
ARES : 123.16 (-5.15%)
GH : 103.10 (-3.08%)
OWL : 10.81 (-4.80%)
$SPX : 6,909.51 (+0.69%)
AKAM : 94.17 (-14.07%)
LYV : 162.67 (+3.31%)
TPG : 44.51 (-0.16%)
RNG : 39.50 (+34.40%)
$IUXX : 25,012.62 (+0.87%)
ZNH26 : 112-300s (-0.03%)
QQQ : 608.81 (+0.88%)
Guardant Health: Q4 Earnings Snapshot

Guardant Health: Q4 Earnings Snapshot

GH : 103.10 (-3.08%)
Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales

Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales

GH : 103.10 (-3.08%)
Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Fourth quarter 2025 revenue growth of 39% broadly driven by strong performance across Oncology and Screening Expects full year 2026 total revenue to grow in the range...

GH : 103.10 (-3.08%)
Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow

Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow

GH : 103.10 (-3.08%)
3 Unprofitable Stocks Walking a Fine Line

3 Unprofitable Stocks Walking a Fine Line

GH : 103.10 (-3.08%)
HASI : 37.28 (+0.40%)
AMCX : 8.35 (-3.13%)
Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open

Patient and Public Health Groups Invited to Apply for Up to 100 Shield Colorectal Cancer Blood Tests to Support Community Screening Events and Educational Outreach in March

GH : 103.10 (-3.08%)
Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. BTIG 13...

GH : 103.10 (-3.08%)
Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

Data published in Journal of Clinical Oncology supports routine use of circulating tumor DNA (ctDNA) testing in management of stage III colon cancer patients

GH : 103.10 (-3.08%)
3 Unpopular Stocks We Think Twice About

3 Unpopular Stocks We Think Twice About

GH : 103.10 (-3.08%)
DECK : 118.69 (+0.53%)
MSM : 93.86 (-0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 126.08
2nd Resistance Point 119.93
1st Resistance Point 111.51
Last Price 103.10
1st Support Level 96.95
2nd Support Level 90.80
3rd Support Level 82.38

See More

52-Week High 120.74
Last Price 103.10
Fibonacci 61.8% 87.94
Fibonacci 50% 77.81
Fibonacci 38.2% 67.68
52-Week Low 34.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar